- JDRF (previously known as the Juvenile Diabetes Research Foundation) is the leading global charitable organization funding type 1 diabetes (T1D) research. Its mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications.
- Since its inception in 1970, JDRF has invested $3 billion CAD in T1D research around the world. Past JDRF research efforts in Canada have helped improve the care of people with this disease, advanced what is possible with clinical islet transplantation, and uncovered new avenues to cure T1D. JRDF’s current research focuses predominantly on finding a cure, as well as improving lives for people with T1D.
- JDRF Canada’s Government Relations Program focuses on increasing public awareness of T1D, increasing federal government funding for T1D research, and ensuring the provinces and territories are providing affordable and accessible coverage for drugs and devices for everyone living with T1D.
- CIHR partners with JDRF Canada through the CIHR-JDRF Partnership to Defeat Diabetes, a landmark collaboration launched in 2017 aimed at improving the quality of life for Canadians living with T1D and driving efforts to find a cure. The Partnership is supporting innovative clinical trials research for T1D and other translational research projects focused on advancing cures for the disease. CIHR and JDRF each committed $15M towards the Partnership, for a total investment of $30M. This Partnership includes funding towards the 100 Years of Insulin Initiative.
- Using novel transplantation strategies and HLA-edited hypoimmunogenic hPSCs to develop a superior islet-like product for T1D treatment
Senior Scientist at the McEwen Stem Cell Institute at University Health Network and Associate Professor, Department of Physiology at the University of Toronto
- Generation of a functionally robust stem cell-based therapy for type 1 diabetes
Team Lead: Dr. Francis Lynn
Associate Professor in the Department of Surgery and School of Biomedical Engineering at the University of British Columbia, and Investigator at the BC Children’s Hospital Research Institute